| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/10/2002 | WO2002036576A1 Phthalazinone derivatives |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036570A1 4-substituted quinolines as antitumor agents |
| 05/10/2002 | WO2002036569A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036567A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036560A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 05/10/2002 | WO2002036556A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | WO2002022600A3 Chemokine receptor binding heterocyclic compounds |
| 05/10/2002 | WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
| 05/10/2002 | WO2002016338A8 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 05/10/2002 | WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 05/10/2002 | WO2001081342A3 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
| 05/10/2002 | WO2001070706A3 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 05/10/2002 | WO2001068063A3 Novel use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 05/10/2002 | WO2001038324A3 Imidazole derivatives and their use as raf kinase inhibitors |
| 05/10/2002 | WO2001034157A9 Protease inhibitors |
| 05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/10/2002 | CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | CA2427589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | CA2425286A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055639 Pyrazole derivatives as herbicides |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202971A2 Pharmaceutical compositions comprising 4-quinolones |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP1043322B1 Vitamin e derivatives |
| 05/08/2002 | EP0807110B1 Enterokinetic benzamide |
| 05/08/2002 | EP0790994B1 Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 05/08/2002 | DE10054932A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections |
| 05/08/2002 | DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | CN1348449A Heteroaryl diazacycloalkanes, their preparation and use |
| 05/08/2002 | CN1348447A 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1348436A Novel ligands of nuclear receptors PPAR's |
| 05/08/2002 | CN1348386A Prucalopride oral solution |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/08/2002 | CN1084330C Cydic amide derivatives |
| 05/07/2002 | US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction |
| 05/07/2002 | US6384224 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease |
| 05/07/2002 | US6384070 Restenosis, kidney diseases, lung diseases |
| 05/07/2002 | US6384061 Hydantoin compounds and methods related thereto |
| 05/07/2002 | US6384060 2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384058 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384057 Compounds as estrogens for treatment of deficiency |
| 05/07/2002 | US6384052 Anticoccidial compounds |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | US6384032 Inhibitors of IL-12 production |
| 05/07/2002 | US6384030 Water soluble azoles as broad-spectrum antifungals |
| 05/07/2002 | US6383521 Sponge extract (wondonin a) with antiangiogenesis and anticarcinogenic properties; non-cytotoxic |
| 05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034728A1 4-n-acyl-δ5-2-oxopiperazines, a process for its preparation and combinatorial libraries thereof |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034699A2 Mammalian metabolites of a tachykinin receptor antagonist |
| 05/02/2002 | WO2002004416A3 Lactam metalloprotease inhibitors |
| 05/02/2002 | WO2001096283A3 Hiv integrase inhibitors |
| 05/02/2002 | WO2001090121A3 Methods and compositions for treating hepatitis c virus |
| 05/02/2002 | WO2001085675A3 Fluorous tagging compounds and their use |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | WO2001023353A3 Method for producing indole derivatives on a solid phase |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | WO2000069841A3 Benzofuranylaminoalcohols |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052410 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 05/02/2002 | US20020052403 Taxane formulations |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052397 Treatment of diseases characterized by excess Th2 cytokines and/ or an excess IgE production. |
| 05/02/2002 | US20020052393 Benzanilides as potassium channel openers |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | EP1201661A1 Heteroaromatic ring compounds |